Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:1:80.
doi: 10.4103/2277-9175.102990. Epub 2012 Oct 31.

Study of promoter methylation pattern of 14-3-3 sigma gene in normal and cancerous tissue of breast: A potential biomarker for detection of breast cancer in patients

A Gheibi  1 , M Kazemi, A Baradaran, M Akbari, M Salehi
Affiliations

Study of promoter methylation pattern of 14-3-3 sigma gene in normal and cancerous tissue of breast: A potential biomarker for detection of breast cancer in patients

A Gheibi et al. Adv Biomed Res. 2012.

Abstract

Background: In recent years, DNA methylation as a main epigenetic modification in human cancer is found as a promising biomarker in early detection of breast cancer. Possible applications of numerous hypermethylated genes have been reported in diagnosis of breast cancer but there has been a little comprehensive study on the clinical usefulness of these genes in breast cancer. The aim of the present study was to investigate the promoter methylation status of 14-3-3 sigma gene with the goal of developing a diagnostic application in breast cancer.

Materials and methods: Totally 40 cases of cancerous and noncancerous tissues were studied. DNA was extracted from tissue samples, and promoter methylation pattern was determined by using methylation-specific polymerase chain reaction.

Results: Methylation pattern of 14-3-3 sigma promoter significantly differed between control and malignant breast tissues (P = 0.001), and there was no remarkable correlation between methylation and age (P > 0.05).

Conclusion: The relationship of promoter methylation of 14-3-3 sigma with development of breast cancer found in this study and confirmed the results of previous reports suggests that we can provide the foundation for possible application of 14-3-3 sigma as a potential biomarker for early detection and monitoring disease status.

Keywords: 14-3-3 Sigma; DNA methylation; early detection.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
MSP analysis of T, cancerous and N normal breast tissue from one patient by U, unmethylated and M, methylated primers. C, control
Figure 2
Figure 2
Comparison of methylation pattern of 14-3-3 sigma promoter region in breast cancer and its adjacent normal tissues
See this image and copyright information in PMC

References

    1. Brooks M. Breast cancer screening and biomarkers. Methods Mol Biol. 2009;472:307–21. - PubMed
    1. Ferlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide 2000. Int J Cancer. 2000. [Last accessed on 2012 Feb 23]. Version 1.0. Available from: http://www.dep.iarc.fr/globocan/globocan.html .
    1. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97:72–81. - PubMed
    1. Montazeri A, Ebrahimi M, Mehrdad N, Ansari M, Sajadian A. Delayed presentation in breast cancer: A study in Iranian women. BMC Womens Health. 2003;3:4. - PMC - PubMed
    1. Nagel GC, Schmidt S, Strauss BM, Katenkamp D. Quality of life in breast cancer patients: A cluster analytic approach.Empirically derived subgroups of the EORTC-QLQ BR 23-a clinically oriented assessment. Breast Cancer Res Treat. 2001;68:75–87. - PubMed